Published Time：

In today's rapidly developing society, enterprises are not only the backbone of the economy, but also important entities in fulfilling social responsibilities and promoting social progress. Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as “Healthy Yuan”), as a large, comprehensive pharmaceutical group in the pharmaceutical industry, has not only achieved remarkable results in R&D innovation and new drug pipelines, but has also made significant contributions to social responsibility.

The long-term development of an enterprise is inseparable from the benign progress of society. While achieving economic benefits, it should also pay attention to social benefits. Therefore, high-quality practice of social responsibility and active promotion of sustainable social development have become the unchanging pursuit of Healthy Yuan. While focusing on innovative drug R&D and promoting the vigorous development of its main business, Mr. Zhu Baoguo, the leader of Healthy Yuan, has always paid attention to people's livelihood needs and led Healthy Yuan to tirelessly practice corporate social responsibility.

For a long time, Healthy Yuan has actively responded to the national call, and has given back to society through various methods such as donating medicines to areas in need, carrying out ecological protection, conducting public welfare science and technology to support the medical and health cause, and sponsoring impoverished students, contributing to the implementation of the national strategy for rural revitalization and social harmonious development. This is not only an important manifestation of corporate social responsibility, but also a necessary requirement for economic entities to promote social progress.

Universal Chronic Disease Prevention and Control to Promote the Construction of Healthy Villages Promoting Rural Revitalization

The Central Committee of the Communist Party of China and the State Council recently issued the "Rural Revitalization Plan ( 2024-2027)" mentioned that it is necessary to promote rural revitalization in a classified manner and promote common prosperity between urban and rural areas. "Promote the construction of healthy villages, improve the medical and health service system, and enhance the ability to respond to major epidemics and public health emergencies."

Healthy Yuan actively participates in the rural revitalization cause, and through various methods such as precise drug donation and industrial support, helps rural areas achieve economic development and social progress, and truly interprets the responsibility and spirit of Chinese enterprises in promoting social development.

In terms of public welfare undertakings in chronic disease management, Healthy Yuan has been at the forefront of the industry. Chronic diseases have become an important factor affecting people's health and quality of life, especially in some mountainous areas in China, where patients lack awareness of the importance of chronic disease management, and the treatment of chronic diseases faces many difficulties. Therefore, Healthy Yuan regards chronic disease public welfare as one of the important directions for fulfilling its social responsibilities, continuously sending warmth and hope to low-income chronic disease patients.

Since 2018, Healthy Yuan and Lizhu Group jointly launched the "Universal Chronic Disease Prevention and Control Public Welfare Project", aiming to focus on common chronic diseases such as hypertension, hyperlipidemia, and cardiovascular and cerebrovascular diseases, to deliver medicines and other materials to chronic disease patients in remote areas, helping patients obtain medicines nearby, reducing patients' medical burden, and improving drug accessibility. It also helps to strengthen local patients' awareness of chronic disease management, helping patients better prevent and control diseases and manage their own health.

Through cooperation with community organizations and government medical institutions, Healthy Yuan's chronic disease public welfare project can accurately identify low-income chronic disease patients and people with special health needs, accurately target donations of medicines, and ensure that donated medicines can be accurately delivered to the patients who need them most. By the first half of 2024, the project has covered 9 provinces and 4 autonomous regions nationwide, and its public welfare footprint has spread to more than 20 regions in Sichuan, Inner Mongolia, Tibet, Xinjiang, Gansu, Guangxi and other places.

In addition, health education is an important means of disease prevention. Healthy Yuan has always been committed to helping vulnerable groups in society improve their quality of life through precise support. It actively participates in community health construction work, organizing health check-ups, setting up health consultation points, and distributing health education materials, covering aspects such as reasonable diet, moderate exercise, and disease prevention, effectively enhancing residents' health awareness and self-care ability, improving the overall health literacy of the masses, and providing substantial help to a large number of low-income chronic disease patients.

Focus on Unmet Clinical Needs

Since its establishment, Healthy Yuan has always adhered to the corporate mission of "For Health, For Tomorrow", and is committed to providing high-quality, safe, affordable, and accessible pharmaceutical products and services to society through the development and growth of its main business. To meet clinical needs, Healthy Yuan has been laying out the research and development of innovative drugs that patients and the market have high hopes for.

In addition, Healthy Yuan recently successfully obtained the clinical trial approval document for a global first-in-class PREP target COPD innovative drug. Currently, Healthy Yuan has reserved more than 20 innovative drugs, covering multiple fields such as respiratory, analgesia, digestive system, cardiovascular and mental diseases. Among them, 7 new drugs have been advanced to Phase II and beyond, and the R&D process is continuously accelerating.

Recently, the 2024 S&P Global Sustainability Assessment results were released, and Healthy Yuan ranked third among the participating pharmaceutical companies in China based on its excellent ESG performance, ranking among the top 5 in the industry. In the future, the company will adhere to innovation-driven development, actively promote the accelerated landing of more innovative drugs with breakthrough efficacy and meeting complex clinical needs, and bring better treatment options to patients. At the same time, it will continue to deepen its social responsibility practices, actively participate in social public welfare undertakings, and contribute more to the health and well-being of patients.


This article is from: CNR.CN